Anza Memon
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on Fatigue and Cognition in Veterans With Multiple Sclerosis (NCT07181811) | Anza Memon | 2025-09-30 |
Track Anza Memon automatically
Every clearance here is in the API, with alerts when new ones post.